Professor, Thoracic/Head and Neck Medical Oncology
Hematology
Dr. Charles Lu, MD
|
|
Give Review
Charles Lu works in the field of Hematology. He went to Yale University School of Medicine. Yale University School of Medicine is a one of the best medicals schools. Yale University School of Medicine has a rank of 7 in research and a 57 in primary care Charles has written publications. He has 15 publications published with PubMed. The lastest paper is: 'Association between Genetic Variants in DNA Double-Strand Break Repair Pathways and Risk of Radiation Therapy-Induced Pneumonitis and Esophagitis in Non-Small Cell Lun...' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Thyroid Gland Malignancies.
- Inflammation-related genetic variants predict toxicity following definitive radiotherapy for lung Cancer.
- Nomogram for Predicting Symptom Severity during Radiation Therapy for Head and Neck Cancer.
- Socioeconomic Status Is Associated with Depressive Severity Among Patients with Advanced Non-Small-Cell Lung Cancer: Treatment Setting and Minority Status Do Not Make ...
- Wnt signaling pathway pharmacogenetics in non-small cell lung Cancer.
- Inflammation-related Genetic Variations and Survival for Advanced Non-Small Cell Lung Cancer Receiving First-line Chemotherapy.
- Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck Cancer: A prospective analysis using the University of Texas MD Anders...
- Telomere Length in Peripheral Blood Leukocytes and Lung Cancer Risk: A Large Case-Control Study in Caucasians.
- Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung Cancer treated with definitive radiation therapy.
- Genome-wide association study of genetic predictors of overall survival for non-small cell lung Cancer in never smokers.
- Prognostic value of patient-reported symptom interference in patients with late-stage lung Cancer.
- High symptom burden prior to radiation therapy for head and neck Cancer: A patient-reported outcomes study.
- Systematic Evaluation of Apoptotic Pathway Gene Polymorphisms and Lung Cancer Risk.
- Association between Genetic Variants in DNA Double-Strand Break Repair Pathways and Risk of Radiation Therapy-Induced Pneumonitis and Esophagitis in Non-Small Cell Lun...
Schools
Yale Univ Sch Of Med
Brigham and Women39s Hospital
Procedures Preformed
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- Bladder Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Brigham and Women's Hospital -
Yale University School of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1487740551 | |
| NPPES Provider LastName | LU | |
| NPPES Provider FirstName | CHARLES | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 310.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 29.0 | |
| Percent Opioid Claims | 9.35 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1487740551 |
| Last Name Of The Provider | LU |
| First Name Of The Provider | CHARLES |
| View All |
Similar Doctors
|
|
Dr. Peter W. McLaughlin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jatin Shah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maro N. Ohanian, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carlos E. Bueso-Ramos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chung C. Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bryan K. Kee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John T. French, MD |
|
|
Dr. Yanyan Lou, MD |
|
Dr. Yuval Raizen, MD
This Doctor is OpenDoctor Recommended.
|